Abstract
There is an urgent need for the identification and validation of new therapeutic targets in protozoan parasites because currently available drugs are limited in number and usefulness, and no vaccines are available. The discovery that alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, is an efficacious treatment for African Sleeping Sickness caused by the protozoan parasite Trypanosoma brucei, has validated the polyamine pathway as a target in protozoan parasites. Polyamines are ubiquitous organic cations that play critical roles in key cellular processes such as growth, differentiation, and macromolecular biosynthesis. In recent years, remarkable progress has been made in the characterization of the polyamine pathway in a variety of protozoan parasites and this review will highlight surprising and unique features that could lead to new therapeutic strategies.
Keywords: Polyamines, parasites, Trypanosoma brucei, Trypanosoma cruzi, Leishmania, Plasmodium, therapeutic strategies.
Current Pharmaceutical Design
Title:Parasite Polyamines as Pharmaceutical Targets
Volume: 23 Issue: 23
Author(s): Sigrid Roberts*Buddy Ullman
Affiliation:
- Pacific University School of Pharmacy, Hillsboro, OR 9712,United States
Keywords: Polyamines, parasites, Trypanosoma brucei, Trypanosoma cruzi, Leishmania, Plasmodium, therapeutic strategies.
Abstract: There is an urgent need for the identification and validation of new therapeutic targets in protozoan parasites because currently available drugs are limited in number and usefulness, and no vaccines are available. The discovery that alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, is an efficacious treatment for African Sleeping Sickness caused by the protozoan parasite Trypanosoma brucei, has validated the polyamine pathway as a target in protozoan parasites. Polyamines are ubiquitous organic cations that play critical roles in key cellular processes such as growth, differentiation, and macromolecular biosynthesis. In recent years, remarkable progress has been made in the characterization of the polyamine pathway in a variety of protozoan parasites and this review will highlight surprising and unique features that could lead to new therapeutic strategies.
Export Options
About this article
Cite this article as:
Roberts Sigrid*, Ullman Buddy , Parasite Polyamines as Pharmaceutical Targets, Current Pharmaceutical Design 2017; 23 (23) . https://dx.doi.org/10.2174/1381612823666170601101644
DOI https://dx.doi.org/10.2174/1381612823666170601101644 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Long-Term Effects of Perinatal Glucocorticoid Treatment on the Heart
Current Pediatric Reviews Novel Strategies for the Detection of Systolic and Diastolic Heart Failure
Current Cardiology Reviews Carbon Monoxide - Toxicity of Low-Dose Application
Current Pharmaceutical Biotechnology Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Tuberculous Pericarditis
Current Cardiology Reviews Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases
CNS & Neurological Disorders - Drug Targets A Deep Neural Network to Distinguish COVID-19 from other Chest Diseases Using X-ray Images
Current Medical Imaging Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Large Unrepaired Aortopulmonary Window Presenting in Adulthood
Current Cardiology Reviews New Insights into the Surgical Management of Tetralogy of Fallot: Physiological Fundamentals and Clinical Relevance
Current Pediatric Reviews Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure
Current Vascular Pharmacology The Failing Heart in Pediatric Dilated Cardiomyopathy Caused by Excessive Water Drinking: A Case Report and Brief Review
New Emirates Medical Journal Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) Moxifloxacin-induced Hypoglycemia in a Non-diabetic Patient
Current Drug Safety Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Current Pharmaceutical Design Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews